Breast Cancer Metastasis (MBC) is an ultimate death sentence remains a challenge for clinicians worldwide.According to the Metastatic Breast Cancer (MBC) Awareness Network about 155,000 patients are living nowadays with MBC, and about 40,000 deaths are reported annually in the United States of America. About 10% of the patients visiting the clinic or appearing at the emergency sittings are diagnosed with stage IV breast cancer at the initial screening and require an urgent and effective treatment, which mainly focuses on controlling the disease and improve the quality of life. A breakthrough in the clinical trials for the treatment of breast cancer metastasis has been observed recently, most of these treatments are mainly drug th...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
The use of more active cytotoxic agents (eg, anthracyclines and taxanes) in the adjuvant setting has...
The discovery of various driver pathways and targeted small molecule agents/antibodies have revoluti...
Despite exciting progress in the understanding of breast cancer development and progression, and in...
Metastasis is the leading cause of breast cancer-associated deaths. Despite the significant improvem...
Metastatic breast cancer (MBC) remains an incurable disease. The aims of treatment include tumour sh...
Metastatic breast cancer (MBC) remains an incurable disease. The aims of treatment include tumour sh...
Breast cancer is one of the leading causes of cancer-related mortality of women in the United States...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
Invasive breast cancer tends to metastasize to lymph nodes and systemic sites. The management of met...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
The discovery of various driver pathways and targeted small molecule agents/antibodies have revoluti...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
The use of more active cytotoxic agents (eg, anthracyclines and taxanes) in the adjuvant setting has...
The discovery of various driver pathways and targeted small molecule agents/antibodies have revoluti...
Despite exciting progress in the understanding of breast cancer development and progression, and in...
Metastasis is the leading cause of breast cancer-associated deaths. Despite the significant improvem...
Metastatic breast cancer (MBC) remains an incurable disease. The aims of treatment include tumour sh...
Metastatic breast cancer (MBC) remains an incurable disease. The aims of treatment include tumour sh...
Breast cancer is one of the leading causes of cancer-related mortality of women in the United States...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
Invasive breast cancer tends to metastasize to lymph nodes and systemic sites. The management of met...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
In women, breast cancer is the most common cancer diagnosis and second most common cause of cancer d...
The discovery of various driver pathways and targeted small molecule agents/antibodies have revoluti...
A distinctive subset of metastatic breast cancer (MBC) is oligometastatic disease, which is characte...
The use of more active cytotoxic agents (eg, anthracyclines and taxanes) in the adjuvant setting has...
The discovery of various driver pathways and targeted small molecule agents/antibodies have revoluti...